LEADER 05480nam 2200649Ia 450 001 9910830864803321 005 20230721022534.0 010 $a1-282-23742-X 010 $a9786612237423 010 $a0-470-71417-4 010 $a0-470-71418-2 035 $a(CKB)1000000000789989 035 $a(EBL)454370 035 $a(SSID)ssj0000354702 035 $a(PQKBManifestationID)11259193 035 $a(PQKBTitleCode)TC0000354702 035 $a(PQKBWorkID)10315926 035 $a(PQKB)11564002 035 $a(MiAaPQ)EBC454370 035 $a(OCoLC)441875050 035 $a(EXLCZ)991000000000789989 100 $a20080814d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aPulmonary infection in the immuno-compromised patient$b[electronic resource] $estrategies for management /$fedited by Carlos Agusti ?and Antoni Torres 210 $aChichester, West Sussex, UK ;$aHoboken, NJ $cJohn Wiley & Sons$d2009 215 $a1 online resource (459 p.) 300 $aDescription based upon print version of record. 311 $a0-470-31957-7 320 $aIncludes bibliographical references and index. 327 $aPULMONARY INFECTION IN THE IMMUNOCOMPROMISED PATIENT STRATEGIES FOR MANAGEMENT; Contents; Preface; List of Contributors; 1 Lung Immune Defences in the Immunosuppressed Patient; 1.1 Introduction; 1.2 Host defence function in health; 1.3 Host defence function in select immunocompromised patients; 1.4 Summary and future directions for this field; 2 Microbiological Diagnosis of Respiratory Infections in the Immunocompromised; 2.1 Introduction; 2.2 HIV infection and Mycobacterium tuberculosis; 2.3 HIV infection and non tuberculous mycobacteria (NTM); 2.4 HIV and Pneumocystis jirovecii 327 $a2.5 Infections in transplant patients or other immunodeficiencies2.6 Concluding remarks; 3 Diagnosis of Pneumonia in Immunocompromised Patient; 3.1 Introduction; 3.2 Clinical assessment; 3.3 Blood cultures; 3.4 Sputum; 3.5 Endotracheal aspirate; 3.6 Non bronchoscopic bronchoalveolar lavage; 3.7 Protected brush sample (PBS); 3.8 Bronchoalveolar lavage (BAL); 3.9 Transbronchial biopsy (TBB); 3.10 Surgical lung biopsy (SLB); 3.11 Sample processing; 3.12 Clinical approach to pulmonary infiltrates in immunosuppressed patient; 3.13 Conclusion; 4 Pulmonary Imaging in Immunocompromised Patients 327 $a4.1 Pulmonary infections in immunocompromised patient4.2 Respiratory infections; 4.3 Interventional procedures in patients with pneumonia; 4.4 Summary; 5 Pulmonary Infections in HIV Patients in the Highly Active Antiretroviral Therapy Era; 5.1 Introduction; 5.2 Epidemology and etiology; 5.3 Diagnosis; 5.4 Prognosis; 5.5 Conclusions; 6 Neutropenia; 6.1 Introduction; 6.2 Management of the neutropenic patient; 6.3 Specific infectious diseases; 7 General Management of Suspected Pneumonia in the Solid Organ Transplant Patient; 7.1 Introduction; 7.2 Epidemiology 327 $a7.3 Differential diagnosis and non-infectious complications7.4 Diagnostic approach; 7.5 Conclusion; 8 Respiratory Infections Following Haematopoietic Stem Cell Transplantation; 8.1 Immune system recovery after HSCT; 8.2 Bacterial pneumonia; 8.3 Invasive pulmonary aspergillosis; 8.4 Cytomegalovirus; 8.5 Community respiratory viruses; 8.6 Non-infectious pulmonary complications; 8.7 Conclusion; 9 Chronic Non-infectious Pulmonary Complications in Haematopoietic Stem Cell Transplantation; 9.1 Introduction; 9.2 Bronchiolitis Obliterans (BO); 9.3 Bronchiolitis Obliterans organizing pneumonia (BOOP) 327 $a9.4 Idiopathic pneumonia syndrome (IPS)9.5 Diffuse alveolar haemorrhage (DAH); 9.6 Peri-engraftment respiratory distress syndrome (PERDS); 9.7 Delayed pulmonary toxicity syndrome (DPTS); 9.8 Pulmonary cytolytic thrombi (PCT); 9.9 Other non-infectious pulmonary complications; 9.10 Summary; 10 Pulmonary Infections in Patients on Chronic Glucocorticoid Treatment; 10.1 Introduction; 10.2 Associated inflammatory response in pneumonia; 10.3 Glucocorticoids: Mechanisms of action; 10.4 Glucocorticoid therapy in clinical practice; 10.5 Diagnostic approach 327 $a10.6 Empirical treatment of suspected pneumonia in patients receiving chronic GC therapy 330 $aThe immuno-compromised patient is more susceptible to a broader range of infections than others, and infections of the respiratory tract are among the first and most common to be encountered. In this book the authors review current options for management for a group of patients that present unique challenges to the clinician, and for whom the choices of effective therapy are often limited.Most up to date book available dedicated specifically to this topicMajor management issue in respiratory medicine for critical care, transplant and cancer patientsReviews important new advan 606 $aRespiratory infections 606 $aLungs$xInfections 606 $aImmunosuppression$xComplications 615 0$aRespiratory infections. 615 0$aLungs$xInfections. 615 0$aImmunosuppression$xComplications. 676 $a616.2/4 676 $a616.24 701 $aAgusti?$b Carlos$01680916 701 $aTorres Marti?$b A$g(Antoni)$0789378 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910830864803321 996 $aPulmonary infection in the immuno-compromised patient$94049973 997 $aUNINA